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A B S T R A C T
Primary malignant schwannoma of the small and large intestine is an extremely rare disease. Therefore, we are go-
ing to report an aggressive multifocal malignant intestinal schwannoma in a 66-year old female patient, that was pri-
marily diagnosed as the gynecological tumor that, even after the surgical treatment, had a very quickly recurrence.
Small intestine tumors may show images similar to an adnexal tumor, so it is difficult to differentiate one from another
prior to the surgery. The patient did not suffer from neurofibromatosis type 1 (NF-1), disease that increases occurrence of
malignant schwannoma in comparison with general population. These tumors are often diagnosed late, and radical sur-
gical intervention does not guarantee longer survival. After surgical removal of macroscopically visible tumor masses
from this patient, tumor formation within one month after the operation had reached the sizes of 83x66 mm and 85x75
mm respectively, with the occurrence of metastases in the liver, and thereafter the patient died. In differential diagnosis of
adnexal tumor small intestine tumor has to be considered, especially if nonspecific symptoms are present.
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Introduction
Malignant schwannoma is malignant disease that emer-
ges from the mezenhimal cells. Malignant schwannoma
belongs to the group of soft tissue sarcomas (STS). The
World Health Organization (WHO) introduced the term
malignant peripheral nerve sheath tumor (MPNST), and
this replaced previous heterogeneous and often confus-
ing terminology of malignant schwannoma, neurilemo-
ma and neurofibrosarcoma1,2. Despite the large presence
of the soft tissues in human body, the soft tissue sarco-
mas are rare tumors and make up to 0.7% of all malig-
nant tumors3. Digestive system sarcomas (make 2% of all
of the sarcomas in adults) are most commonly found in
stomach (47%), small intestine (35%), large intestine and
rectum (12%) and esophagus (5%)4. The most common
histological type is leiomyosarcoma (75.1%), while the
other types are considerably less common. MPNST ma-
kes 1% of all digestive system sarcomas. The incidence of
MPNST is 1/100 000 and constitutes 3–12% of the STS1,5.
More often occur in males (the male to female ratio is
3.8:1)1. MPNST may occur on any part of the nervous
system, but most commonly is found on body, limbs,
head, neck and paravertebral region6–8. It may rarely oc-
cur in alimentary system, and extremely rarely in esoph-
agus, small and large intestine4,6,8. Localization of malig-
nant schwannoma on female reproductive organs is ex-
tremely rare. There are only a few cases of ovary or
uterus malignant schwannoma reported in relevant lite-
rature9,10. Frequency of malignant schwannoma among
patients with neurofibromatosis type 1 (NF-1) is greater
than in general population and is estimated to be 2–5%11–13.
Case Report
A 66-years old, obese female patient was admitted to
the hospital due to severe suprapubic pain. The patient
339
Received for publication October 29, 2009
was conscious, contactable, and cardiopulmonary com-
pensated. Her regularity was well, with no traces of blood
or phlegm. She complained about persistent pressure
during urination. She suffered from heart arrhythmia,
arterial hypertension, diabetes type 2, chronic obstruc-
tive pulmonary disease (COPD), and hyperlipoproteine-
mia. There was no family history of NF-1 or malignant
diseases.
Gynecological clinical exam revealed hardly mobile,
palpable mass in lower abdomen, approximately 20 cm in
diameter, which reaches her umbilicus. The laboratory
test showed elevated CRP 41.9 mg/L. Other results were
normal (L 9.78x109/L, E 4.9x1012/L, Hb 137 g/L, Htc 0432
L/L, TCR 297x109/L, normal urine value). CA125–22
kUI/L. The ultrasound imagining showed the tumor in
the abdomen, most probably of gynecological origin. Com-
puted tomography (CT) findings of the abdomen (Figure
1) showed a lobular lesion with heterogeneous structure,
17 cm in diameter, located in the lesser pelvis (Figure 1a),
spreading to the central part of the abdomen (Figure 1b),
as well as another lesion of a similar characteristics, 7 cm
in diameter, left in the abdomen (Figure 1c). The liver
was normal size, homogeneous structure, with normal
coefficient of absorption, without suspicious changes
(Figure 1d). There were no enlarged lymph nodes. The
bladder was pushed up.
The patient was transferred to the University Hospi-
tal for Tumors for surgical treatment. Prior to the sur-
gery, general surgeons were consulted as possible pri-
mary settlement of the tumor might have been the
intestine. During the surgical procedure (Figure 2a-d) a
tumor, approximately 20 cm in diameter, located in me-
sentery of ileum was found. The tumor has infiltrated
the ileum and cecum and overlapped the dome of the
bladder. The other tumors, approximately 7 cm and 3 cm
in diameter, were found in mesentery of jejunum and in
mesocolon of descending colon. A few tumor masses of 1
cm were also found on omentum.
The surgical procedure was carried on by the team
consisted of general surgeons and gynecologists. All of
the described tumors were removed in their entirety, in-
cluding resection of part of jejunum, resection of ileum
and subtotal colectomy and omentectomy. At the end of
surgery exploration of abdominal cavity displays normal
uterus and both adnexas. The specimens were sent for
the pathohistological and immunohistochemical analysis.
The post-operative period passed without any compli-
cations. Pathohistological and immunohistochemical anal-
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Fig. 1. Computed tomography (CT) findings before surgery a) tu-
mor in the lesser pelvis b) tumor in the central part of abdomen c)
tumors occupied the left and central part of the abdomen d) liver
without suspicious changes.
Fig. 2. Surgery a) mobilized tumor mass with small intestine,
lateral view b) the tumor located in mesentery of ileum prior to
extraction c) rough measuring of the tumor mass d) surgically
removed tumor mass.
Fig. 3. Immunohistochemical reactions a) hemalaun eosin with
pathological mitotic figures (microscopic magnification 200x) b)
glial fibrillary acidic protein (GFAP) (microscopic magnification
200x) c) vimentine (VIM) (microscopic magnification 200x) d)
neuron-specific enolase (NSE) (microscopic magnification 200x).
ysis confirmed the diagnosis of poorly differentiated (high
grade) malignant schwannoma, under Coindreu classi-
fied as high sarcoma gradus15. Histological report re-
vealed that the tumors were composed of elongated spin-
dle cells displaying eosinophilic, partially translucent,
light-colored cytoplasm and hyper chromatic nuclei ar-
ranged in a storiform pattern. Twelve mitotic figures
(Figure 3a) per 10 HPF were counted, and there were
large foci of necrosis that occupied more than 50% of tu-
mor tissue. Immunohistochemical analysis of tumor cells
revealed their positive reaction for glial fibrillary acidic
protein (GFAP) (Figure 3b), vimentine (Figure 3c), a fo-
cal positive reaction for neuron-specific enolase (NSE)
(Figure 3d) and CD 68 (data not shown). Reactions for
CD 117 (c-KIT), CD 34, smooth muscle actin (SMA),
transverse striated actin, S–100, neurofilament, CD 99,
synaptophysin, chromogranin, CD 3, CD 20 and leuko-
cyte common antigen (LCA) were negative.
One month after the operation, during the scheduled
check up examination, a recurrent tumor was diagnosed.
The ultrasound showed two tumor masses in pelvis: one
83x66 mm, and the other 85x75 mm. CT images of abdo-
men (Figure 4) showed several spheroid areales extruded
between small intestines toward the bottom of the pelvis,
pushing up the bladder (Figures 4a-c). The bladder sho-
wed no signs of infiltrations, but it seemed that the tu-
mors infiltrated the uterus and adnexas. In the area of
1st segment of the liver close to hilus, the native images
showed the hypodense lesion. The post-contrast images
showed the focus of secondary deposit (Figure 4d). Based
on these findings, this lesion was strongly suspected of
being a metastasis. There were several small paraaortic
lymph nodes.
The patient was hospitalized two days before starting
of the planned chemotherapy, due to severe abdominal
pain and signs of cardiopulmonary decompensation. Im-
mediately after hospitalization and 40 days after the sur-
gery, the patient died. Family did not allow the autopsy.
The patient, according to hospital documentation, died
due to cardiorespiratory failure caused by dissemination
of tumor.
Discussion
Observing this case of rare malignant schwannoma of
the digestive tract, some of specifics have been noticed.
CT and ultrasound examinations displayed gynecological
tumor, while surgical intervention has determined diges-
tive system as an exact location. Although all of the tu-
mor masses were removed during the surgical interven-
tion, the ultrasound and CT performed one month later
have showed recurrence of the disease. Such a fast devel-
opment of tumors, which resulted in growth of 83x66
mm and 85x75 mm, is extremely rare. The patient did
not suffer from NF-1, the disease in which the frequency
of malignant schwannoma is higher in comparison with
general population11,13. All of these characteristics are
rare in general practice, while the combination of them is
unique case. Location and size of malignant schwan-
noma of the digestive tract are most important factors
that have an effect on clinical features of this disease.
The symptoms are usually non-specific. Cramps or dif-
fuse pain and melena are the most common symptoms of
malignant schwannoma of the digestive tract6. Palpable
tumor is present in 25% of patients14. Obstruction of the
intestine is often present, although most of the malig-
nant schwannomas grow extraluminal in subserosa6,15.
The characteristic of these tumors is multifocality, and it
means that several primary tumors of same histological
structure emerge on different locations16.
It is impossible to diagnose malignant schwannoma
based on symptoms and clinical condition of the patient
prior to the surgery. The combination of pathohistolo-
gical and immunohistochemical analysis of tumor tissue
is crucial in diagnosing process, as well as in differentia-
tion from the other soft tissue sarcomas, especially syno-
vial sarcoma, leiomyosarcoma and fibrosarcoma7,16. In
this case, from the point of histology, possible tumors
were: spindle cell sarcoma, gastrointestinal stromal tu-
mor (GIST), gastrointestinal autonomic nerve tumor
(GANT), leiomyosarcoma, and primitive neuroectoder-
mal tumor (PNET). The final diagnosis was set after
immunohistochemical analysis. The location of tumor,
histological picture, positive imunohistochemical reac-
tions for GFAP and VIM (Figures 3b and c), a focal posi-
tive reaction for NSE (Figure 3d) and CD 68, negative
imunohistochemical reactions for CD 117 (c-KIT), CD
34, SMA, S – 100, neurofilament, CD 99, synaptophysin,
chromogranin, CD 3, CD 20, LCA and large number of
pathological mitotic figures (Figure 3a) were crucial for
final diagnosis of malignant schwannoma and differenti-
ation from other soft tissue sarcomas. All forms of spin-
dle cell sarcoma (spindle cell fibrosarcoma, spindle cell
chondrosarcoma, spindle cell sarcomatosis mesothelioma,
spindle cell rhabdomiosarcoma, angiosarcoma spindle
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Fig. 4. Computed tomography (CT) findings one month after sur-
gery a) tumors in the abdomen b) tumors extruded between small
intestines toward the bottom of the pelvis c) tumors in greater pel-
vis d) metastasis in the liver.
cell and spindle cell liposarcoma) were excluded due to
tumor localization, histological picture and imunohisto-
chemical reactions in tumor tissue. It is important to
note that CD 34 is not specific marker for nerve tumors.
CD 34 is used for endothelial and myofibroblastic differ-
entiation of tumors and for evaluation of angiogenesis.
Gastric schwannomas are usually positive for GFAP and
contain occasional CD 34 positive cells. However, they
are negative for CD 117 (c-KIT), desmin and SMA17.
Diagnosis and treatment of intestinal malignant sch-
wannoma requires a multidisciplinary approach. Radiol-
ogists, gynecologists, surgeons, pathologists and inter-
nists-oncologists participated in the diagnosis, treatment
planning and treatment of our patient.
The treatment is carried out using all three in oncol-
ogy accepted procedures: the surgical intervention, radi-
ation and chemotherapy, applied individually or in com-
bination. The choice of treatment depends on the clinical
stage of disease and level of maturity of cellular elements
that form the tumor18. Only surgical intervention pro-
vides an opportunity for the recovery7,19. Intestinal ma-
lignant schwannoma poorly responds on radiotherapy
and chemotherapy19. The accurate diagnosis happens of-
ten late7, which then follows palliative surgical treat-
ment that, in combination with radiotherapy and chemo-
therapy, in some patients results as an improvement.
Remission after chemotherapy has been reported, but
without controlled studies7. Close postoperative observa-
tion is recommended because of the tendency to recur-
rence and metastasis7,19.
There are three crucial parameters in determining
the degree of malignancy: tumor differentiation, mitotic
activity, and degree of tumor necrosis18. Histological gra-
ding is the most important prognostic factor and the best
indicator of metastatic risk in adult STSs. It predicts ap-
pearance of distant metastasis as well as overall survival,
but not likelihood of recurrence of the local disease18.
The 5-year survival rate of intestinal malignant schwan-
noma is unknown7. Reviewing the relevant literature we
found that only four patients from twenty nine survived
5 years and longest period of survival was 9.5 years6,20.
Conclusion
The primary intestinal malignant schwannoma is ex-
tremely rare4,20,21. Based on presented case and all rele-
vant facts, these tumors are usually not diagnosed on
time7,19, while radical surgical intervention does not gua-
rantee longer survival. Tumors of the small intestine
may show images similar to an adnexal tumors, so it is
difficult to differentiate them prior to surgery22,23. Al-
though such cases are so rare, when stating the differen-
tial diagnosis of adnexal tumors, possibility of a small in-
testine tumor should always be kept on mind, especially
when non-specific symptoms are present, as well as when
is not possible to positively determine the origin of tumor
by diagnostic exams.
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AGRESIVNI MALIGNI [VANOM CRIJEVA KOJI OPONA[A GINEKOLO[KU PATOLOGIJU:
PRIKAZ SLU^AJA
S A @ E T A K
Primarni maligni {vanom tankog i debelog crijeva je iznimno rijetka bolest. U ovom slu~aju radilo se o multifokal-
nom malignom {vanomu probavnog sustava u 66-godi{nje pacijentice, koji je primarno dijagnosticiran kao ginekolo{ki
tumor, a nakon provedenog kirur{kog lije~enja iznimno je brzo recidivirao. Tumori lokalizirani u tankom crijevu mogu
dati sliku tumora adneksa i stoga ih je te{ko preoperativno diferencirati. Pacijentica nije bolovala od neurofibromatoze
tipa 1, kod koje je u~estalost malignih {vanoma vi{estruko ve}a nego u op}oj populaciji. Dijagnoza ove vrste tumora
naj~e{}e se postavlja u uznapredovalom stadiju bolesti, a kirur{ko lije~enje ne jam~i du`e pre`ivljavanje. Nakon kirur-
{kog uklanjanja makroskopski vidljivih tumorskih masa, tumorske tvorbe su unutar mjesec dana nakon zahvata doseg-
le veli~inu 83x66 mm i 85x75 mm uz pojavu metastaze u jetri, nakon ~ega je pacijentica preminula. U diferencijalnoj
dijagnozi tumora adneksa uvijek treba pomisliti na tumor tankog crijeva, osobito ukoliko su prisutni nespecifi~ni simp-
tomi.
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